pI: 4.4194 |
Length (AA): 390 |
MW (Da): 44522 |
Paralog Number:
0
Signal peptide: N | GPI Anchor: N | Predicted trans-membrane segments: 0
Targets have been classified into druggability groups (DG) according to their druggability score in network driven prioritizations. DGs range from 1 to 5; the higher the group number, the higher the chance of the target to be druggable
Modbase 3D models:
There are 3 models calculated for this protein. More info on
these models, including the
models themselves is available at:
Modbase
Target Beg | Target End | Template | Template Beg | Template End | Identity | Evalue | Model Score | MPQS | zDope |
---|---|---|---|---|---|---|---|---|---|
144 | 192 | 2d8q (A) | 15 | 62 | 33.00 | 0 | 0.69 | 0.450041 | 0.06 |
144 | 192 | 2od1 (A) | 660 | 707 | 27.00 | 0 | 0.23 | 0.353041 | -0.03 |
147 | 189 | 2d8v (A) | 11 | 62 | 44.00 | 0.27 | 0.39 | 0.112756 | 0.99 |
Help me make sense of these data.
A more detailed description of these scores is available at the Modbase Model Evaluation Help Pages, and in the papers referenced therein.
PDB Structures:
Ortholog group members (OG5_129167)
Species | Accession | Gene Product |
---|---|---|
Arabidopsis thaliana | AT4G02220 | MYND type zinc finger and programmed cell death 2 C-terminal domain-containing protein |
Babesia bovis | BBOV_IV003300 | programmed cell death protein 2, putative |
Brugia malayi | Bm1_41630 | Programmed cell death protein 2, C-terminal domain containing protein |
Caenorhabditis elegans | CELE_R07E5.10 | Protein PDCD-2, isoform A |
Cryptosporidium hominis | Chro.20362 | programmed cell death 2 |
Cryptosporidium parvum | cgd2_3420 | programmed cell death 2, putative |
Dictyostelium discoideum | DDB_G0284069 | hypothetical protein |
Drosophila melanogaster | Dmel_CG3260 | Zinc finger protein RP-8 |
Echinococcus granulosus | EgrG_000599000 | programmed cell death protein 2 |
Entamoeba histolytica | EHI_062760 | programmed cell death protein 2, putative |
Echinococcus multilocularis | EmuJ_000917400 | pcdc2:rp 8 (programmed cell death protein 2) |
Echinococcus multilocularis | EmuJ_000599000 | programmed cell death protein 2 |
Homo sapiens | ENSG00000071994 | programmed cell death 2 |
Leishmania braziliensis | LbrM.21.1180 | hypothetical protein, conserved |
Leishmania donovani | LdBPK_211190.1 | Programmed cell death protein 2, C-terminal putative domain containing protein, putative |
Leishmania infantum | LinJ.21.1190 | hypothetical protein, conserved |
Leishmania major | LmjF.21.0950 | hypothetical protein, conserved |
Leishmania mexicana | LmxM.21.0950 | hypothetical protein, conserved |
Loa Loa (eye worm) | LOAG_06102 | programmed cell death protein 2 domain-containing protein |
Mus musculus | ENSMUSG00000014771 | programmed cell death 2 |
Oryza sativa | 4332566 | Os03g0300200 |
Plasmodium berghei | PBANKA_0613900 | conserved Plasmodium protein, unknown function |
Plasmodium falciparum | PF3D7_0716200 | conserved Plasmodium protein, unknown function |
Plasmodium knowlesi | PKNH_0310800 | conserved Plasmodium protein, unknown function |
Plasmodium vivax | PVX_000615 | hypothetical protein, conserved |
Plasmodium yoelii | PY01026 | Homo sapiens dJ191N21.1-related |
Schistosoma japonicum | Sjp_0032660 | DNA excision repair protein haywire, putative |
Schistosoma mansoni | Smp_165560 | pcdc2/rp-8 (programmed cell death protein 2) |
Trypanosoma brucei gambiense | Tbg972.10.1180 | hypothetical protein, conserved |
Trypanosoma brucei | Tb927.10.1200 | Programmed cell death protein 2, C-terminal putative domain containing protein, putative |
Trypanosoma congolense | TcIL3000_10_1000 | hypothetical protein, conserved |
Trypanosoma cruzi | TcCLB.509967.80 | Programmed cell death protein 2, C-terminal putative domain containing protein, putative |
Trypanosoma cruzi | TcCLB.509695.60 | Programmed cell death protein 2, C-terminal putative domain containing protein, putative |
Theileria parva | TP01_1090 | hypothetical protein |
Gene/Ortholog | Organism | Phenotype | Source Study |
---|---|---|---|
Tb927.10.1200 | Trypanosoma brucei | significant loss of fitness in bloodstream forms (3 days) | alsford |
Tb927.10.1200 | Trypanosoma brucei | significant gain of fitness in bloodstream forms (6 days) | alsford |
Tb927.10.1200 | Trypanosoma brucei | no significant loss or gain of fitness in procyclic forms | alsford |
Tb927.10.1200 | Trypanosoma brucei | significant gain of fitness in differentiation of procyclic to bloodstream forms | alsford |
CELE_R07E5.10 | Caenorhabditis elegans | embryonic lethal | wormbase |
CELE_R07E5.10 | Caenorhabditis elegans | larval arrest | wormbase |
CELE_R07E5.10 | Caenorhabditis elegans | larval lethal | wormbase |
CELE_R07E5.10 | Caenorhabditis elegans | slow growth | wormbase |
CELE_R07E5.10 | Caenorhabditis elegans | sterile | wormbase |
PBANKA_0613900 | Plasmodium berghei | Essential | plasmo |
nmpdr | Genome-scale essentiality datasets from published studies (M. tuberculosis) | National Microbial Pathogen Data Resource |
alsford | High-throughput phenotyping using parallel sequencing of RNA interference targets in the African trypanosome | Genome Res 2011, 21:915-924 |
gerdes | Experimental determination and system-level analysis of essential genes in E. coli MG1655 | Gerdes et al., J Bacteriol. 2003 185:5673-84 |
blattner | Systematic mutagenesis of the E. coli (MG1655) genome | J Bacteriol 2004, 186:4921-4930 |
keio | Systematic single-gene knock-out mutants of E. coli K12 | The Keio Collection |
neb | C. elegans RNAi phenotypes | Data obtained from Wormbase WS150, curated by K. Chaudary and T. Carlow, New England Biolabs |
wormbase | C. elegans RNAi experiments | WormBase web site, http://www.wormbase.org, release WS170 |
shigen | Profiling of E. coli Chromosome (PEC) | National Institute of Genetics, Japan |
yeastgenome | Systematic deletion of yeast genes | Saccharomyces Genome Database |
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
In any case, if you have information about papers containing relevant validation data for this target, please contact us.